1-3 of 3
G. Cimino, MD
Close
Sort by
Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD
Journal: Blood
Blood (2006) 108 (11): 638.
https://doi.org/10.1182/blood.V108.11.638.638
Published: 2006
Journal Articles

Valproic Acid Plus Retinoic Acid Induce Myeloid Differentiation in Chemotherapy-Resistant Acute Myeloid Leukemia Patients.

C. Nervi, MD, F. Lo Coco, MD, S. Minucci, MD, A. Careddu tech., R. Fiorini, MD, E. Finolezzi, MD, N. Noguera, PHD, L. Travaglini, PHD, V. Gelmetti, PHD, D. Diverio, PHD, S. Fenu, MD, M. Mancini, MD, C. Tatarelli, MD, M.A. Aloe Spiriti, MD, M.C. Petti, MD, G. Cimino, MD, F. Mandelli, MD, S. Amadori, MD, P.G. Pelicci, MD
Journal: Blood
Blood (2004) 104 (11): 1805.
https://doi.org/10.1182/blood.V104.11.1805.1805
Published: 2004
Journal Articles

Clinical Impact of Q-RT-PCR Monitoring of Minimal Residual Disease in Newly Diagnosed Adult Patients with BCR-ABL+ Acute Lymphoblastic Leukemia Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PHD, G. Meloni, MD, L. Annino, MD, A. Chiarenza, MD, G. Martinelli, MD, F. Pane, MD, M. Montanaro, MD, P. Chiusolo, MD, A. Santoro, MD, M. Offidani, MD, M. Vignetti, MD, G. Saglio, MD, M. Baccarni, MD, F. Mandelli, MD, Robert Foa, MD
Journal: Blood
Blood (2004) 104 (11): 1082.
https://doi.org/10.1182/blood.V104.11.1082.1082
Published: 2004